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Abstract 
Background: Infection with Serratia spp. have been associated with mastitis outbreaks in dairy cattle herds. Environ‑
mental contamination or a point source, like a teat dip product, have often been observed to be potential sources of 
such outbreaks. We describe two Serratia marcescens associated mastitis outbreaks associated with a contaminated 
teat dip containing a tertiary alkyl amine, n,n‑bis (3‑aminopropyl) dodecylamine in two dairy cattle farms in Finland. S. 
marcescens strains isolated from milk and environmental samples were identified by the MALDI‑TOF method.
Results: Six specimens (n = 19) on Herd 1 and all specimens (n = 9) on Herd 2 were positive for S. marcescens. Positive 
specimens were from mastitis milk and teat dip liquid and equipment. Bacteria were not isolated from the unopened 
teat dip canister. The same clone of S. marcescens was isolated from milk samples and teat dip samples within the 
farms. Pulsed field gel electrophoresis results to the S. marcescens isolates from these two different herds were tested 
with unweighted pair‑group method using arithmetic average clustering analysis. The isolates were not same clone in 
both herds, because similarity in that test was only 75% when cut‑off value to similarity is 85%.
Conclusions: Our investigation showed that the post milking teat dip and/or temporary containers were contami‑
nated with S. marcescens and these were most likely the sources for new mastitis cases. The negative result from the 
unopened teat dip canister and positive results from refillable containers demonstrated that the product itself was 
not contaminated with S. marcescens at the production unit, but became contaminated at the farm level.
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Background
Serratia species are rod-shaped Gram-negative bacte-
ria, which were recently classified under the new family 
of the order Enterobacterales: Yersiniaceae [1]. To date, 
20 different Serratia spp. have been described [2]. Ser-
ratia spp., in particular Serratia marcescens, and Serra-
tia liquefaciens are ubiquitous environmental bacteria 
capable of causing opportunistic infections in humans 
and many animal species [3] including mastitis in dairy 
cows [4]. These organisms have been isolated from water, 
soil, different types of plants and insects [5], farm envi-
ronment like bedding [6] and milking parlor [7] and from 
feces of dairy cows [3, 7]. Serratia spp. have also been 
detected in 1.3–2% of bulk tank milk samples [8, 9]. Ser-
ratia spp. can form biofilm on inanimate surfaces [3] and 
produce heat resistant enzymes, thus they are capable of 
causing spoilage at different points of milk processing 
[10, 11]. However, certain subspecies like S. liquefaciens 
can also be beneficial by contributing to ripening of raw 
milk cheese products due to their proteolytic activity 
[12].
Serratia marcescens and S. liquefaciens have been asso-
ciated with mastitis outbreaks in dairy cattle herds [6, 13, 
14]. Environmental contamination, or a point source that 
harbours the bacterium, has often been observed to be a 
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potential source of the outbreaks [15, 16], similar to out-
breaks in human hospitals [17]. We describe two S. marc-
escens mastitis outbreaks associated with a contaminated 
teat dip in two dairy farms in Finland. In addition, the 
literature about Serratia spp. mastitis outbreaks in dairy 
cows is reviewed.
Methods
Farms and data collection
Owners of two dairy farms, located over 300  km apart, 
contacted the Production Animal Hospital of the Faculty 
of Veterinary Medicine, University of Helsinki, in 2016 
due to several Serratia mastitis cases that had occurred 
on the farms during the past years. The first case of S. 
marcescens from mastitis milk sample in Herd 1 was in 
August 2011, and in Herd 2 in September 2016. After the 
farmer contacts, an outbreak investigation was initiated 
to find a possible source of the organism and to control 
the outbreaks.
Information on farm type, herd size, annual milk yield, 
milking and hygienic practices, including the use of dis-
infectants, and laboratory reports of tested mastitis milk 
samples (from 2014 to 2016) were obtained from the 
farmers. Milk samples had been tested in a milk process-
ing company’s laboratory (Valio Ltd, Lapinlahti, Finland) 
using multiplex real-time PCR method (PathoProof™ 
Mastitis Complete-16 Kit, A Thermo Scientific™, Van-
taa, Finland). Data about udder health in the herds were 
retrieved from the national health care recording system, 
ETT Naseva [18], per the owners’ permission.
Sample collection
During the farm visit (08/2016) to Herd 1 to investigate 
the outbreak, all lactating cows (n = 33) were tested with 
the California Mastitis Test (CMT). Quarter milk sam-
ples for bacteriological culture were collected by the 
investigating veterinarian from all quarters that showed 
CMT score > 2 (n = 5) on a 1–5 scale [19]. Milk sam-
ples were collected into 10 mL plastic tubes (Linkoputki 
16 × 100 mm Plastone, Mekalasi, Helsinki, Finland). One 
of the five samples was from an acute mastitis case and 
the rest were from subclinical mastitis. In addition, one 
frozen quarter milk sample from the most recent acute 
mastitis case that had occurred within a week prior to the 
herd visit was available for testing. Thus, six mastitis milk 
samples were cultured from Herd 1.
To find the potential source of S. marcescens in the 
environment, surface samples for bacteriological culture 
were taken using sterile cotton swabs (M40, Transystem 
Amies Agar Gel without charcoal, Copan Diagnostics, 
CA, USA) from a water faucet (n = 1), milking unit lin-
ers (n = 2), washing centres of the milking units (n = 2), 
water cups of the cows (approximately 5 × 5  cm area) 
(n = 1) and from the nozzle of the teat dip spray bot-
tle (n = 1). Also, 5 mL samples of water from the bucket 
(n = 2), where udder towels were kept during milking, 
and from the teat dip product (n = 3) were collected into 
the same kind of sterile plastic tubes as milk samples. The 
specimens from the teat dip product were collected by 
spraying the teat dip product from a refillable spray bot-
tle, by pumping it through a reusable plastic pump that 
was attached to the original opened canister, as well as by 
taking the product straight from an opened canister. In 
addition, five litres of drill well water was collected into 
a sterile can for bacteriological investigation. In total, the 
number of environmental samples was 13.
Samples (n = 9) from Herd 2 were collected by the 
farmer. These consisted of quarter milk samples from two 
cows, each with one clinical mastitis quarter, and seven 
teat dip samples. The teat dip product from an opened 
teat dip canister (n = 1), and all teat dip spray bottles 
(n = 6) were sampled as described for Herd 1.
In addition, a new, unopened 20 L canister of the teat 
dip product (Viri-Dip Plus, Oy Teollisuushankinta TH 
Ab, Kokkola, Finland) was ordered straight from the 
importer of the product to our laboratory to test the bac-
terial quality of the product.
Microbiological methods
Culturing and identification
All samples were cultured immediately after arrival to 
the Laboratory of Production Animal Hospital (Univer-
sity of Helsinki, Mäntsälä, Finland). Culture swabs and 
10 µL of fluid samples (milk, teat dip and bucket water) 
were streaked onto 5% sheep blood agar plates (Tammer-
Tutkan Maljat Oy, Tampere, Finland), and incubated in 
ambient air at 37 °C for up to 48 h. Preliminary identifica-
tion of the species was made according to the guidelines 
of NMC [20].
Well water specimen (5 L) was filtered through a com-
mercial membrane filter with a pore size of 0.45 µm (Mil-
lipore Corporation, MA, USA), after which the filter was 
placed aseptically on a nonselective chromogenic agar 
(UriSelect, Bio-rad Finland Oy, Helsinki, Finland), and 
incubated at 35 °C for up to 48 h.
Identification of the isolates, that were tentatively 
identified as Serratia spp. based on colony and bac-
terium morphology, were further confirmed in the 
Clinical Microbiology Laboratory of the Faculty of Vet-
erinary Medicine (University of Helsinki, Finland), by 
matrix-assisted laser desorption ionization-time of flight 
mass spectrometry using MALDI Biotyper Microflex 
LT (Bruker Daltonics GmbH, Bremen, Germany) and 
MALDI Biotype MSP Identification Standard Method 
1.1.; using score ≥ 2.00 for species level identification. In 
addition, 16S rRNA gene sequence based identification 
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was performed for seven isolates. Bacterial superna-
tant in InstaGene Matrix (Bio-Rad Laboratories Inc., 
CA, USA) was used as a DNA template. The 16S rRNA 
gene was amplified with 0.25 µM of universal primers F8 
5′-AGA GTT TGA TCC TGG CTC AG-3′ and R1541–1522 
5′-AAG GAG GTG ATC CAG CCG CA-3′ [21]. The ampli-
cons were sequenced with primers F19–38 5′-CTG GCT 
CAG GAY GAA CGC TG-3′ [22], R519 5′-GTA TTA CCG 
CGG CTG CTG -3′ [23], F926 5′-AAC TCA AAG GAA 
TTG ACG G-3′ [24], and with R1541–1522. The trimmed 
sequences of 1500 base pairs were analysed by CLC Main 
Workbench Software (version 8.0, Qiagen, Denmark) and 
compared to the BLAST/NCBI database [25] for bacte-
rial identification.
The susceptibility testing was done with a disk diffu-
sion method [26, 27] for the following antimicrobials: 
amikacin, cefpodoxime, enrofloxacin, gentamicin, mero-
penem and sulfamethoxazole/trimethoprim (Oxoid Ltd, 
Hampshire, UK). Of these cefpodoxime, amikacin and 
meropenem were tested only for resistance surveillance 
purposes. Production of ESBL and AmpC enzymes was 
investigated with ESBL and AmC Detection Disk Set 
together with ESBL/AmpC Calculator (Mast Group Ltd, 
Merseyside UK).
Genotyping of S. marcescens strains
Fresh overnight cultures were used to prepare agar 
blocks for pulsed field gel electrophoresis (PFGE). Bac-
terial mass was suspended into cold 100  mM EDTA to 
achieve density of 8.5 McFarland units (Den-1B McFar-
land Densitometer, Grant-bio, Grant Instruments Ltd., 
Cambridgeshire, UK), followed by heating in +75  °C 
for 10 min [28]. After this the PulseNet Escherichia coli 
O157 PFGE protocol [29] with digestion of XbaI enzyme 
(New England Biolabs Inc., MA, USA) was followed. 
Separation of DNA fragments was done by using Chef 
DR III system (Bio-Rad Laboratories Inc., CA, USA). 
The fragments were visualized by SYBR Safe DNA stain-
ing (Thermo Fisher Scientific, Waltham, MA, USA) and 
imaged with AlphaImager HP (Alpha Innotech, Genetic 
Technologies Inc., FL, USA). PFGE patterns were exam-
ined using GelComparII software (version 6.6 Applied 
Maths NV, Belgium) to perform UPGMA (unweighted 
pair-group method using arithmetic average clustering) 
based analysis with the Dice similarity coefficient. Simi-
larity cut-off was 85% to separate clusters and optimiza-
tion and position tolerance were both set at 1.5%.
Literature review
Literature search concerning Serratia spp. in dairy 
cows was performed by utilizing Pubmed (https ://www.
ncbi.nlm.nih.gov/pubme d/) and Web of Science (https 
://webof knowl edge.com/) databases. Keywords used 
for the search were ‘cow’ AND ‘mastitis’ AND ‘Serratia’ 
AND as subject-specific terms. All article types were 
included and reference lists in these were scanned to 
identify additional references that were not found in 
electronic database search.
Results
Background information on both herds is summa-
rised in Table  1. Both farms were tie stall herds with 
less than 50 cows (Ayrshire, Herd 1; Holstein–Friesian, 
Herd 2) with average milk production > 10,000  L/year/
cow. The herds did not have any apparent problems in 
their hygienic practices or in the farm environment. In 
both herds, quarter milk samples for bacteriological 
testing were taken routinely if clinical signs of mastitis 
were observed or if elevated cell count of the milk was 
detected.
In Herd 1, since the first case of S. marcescens in 
August 2011 S. marcescens DNA had been isolated from 
35 milk samples (8/2011–8/2016). Of the milk samples 
analysed during the period of 2014–2016, 71% (90/126) 
were positive for pathogens included in the PCR kit 
used in the testing laboratory. DNA of S. marcescens was 
observed in 39% of the positive samples (35/90). Other 
bacteria detected were non-aureus staphylococci (NAS, 
n = 33/90, 37%), Staphylococcus aureus (n = 10/90, 11%), 
E. coli (n = 6/90, 7%) and miscellaneous bacterial species 
(n = 6/90, 7%). S. marcescens mastitis cases and somatic 
cell count (SCC) in bulk milk are shown on the time-
line in Fig.  1a. The number of treated mastitis cases in 
the herd varied from 5 to 28/100 cows/year during years 
in 2012–2016, being the highest a year after the first S. 
marcescens mastitis case. A marked proportion of all 
cows (23%) was slaughtered during the year 2012 because 
of S. marcescens mastitis. No antimicrobial treatments 
had been given to S. marcescens infected cows.
In Herd 2, the first case of S. marcescens mastitis was 
observed in September 2016. During the period of 
2015–2017, 43 mastitis milk samples had been analysed 
with the PCR-method, of which 26 (60%) yielded posi-
tive results. DNA of S. marcescens was detected in nine 
samples (n = 9/26, 35%), followed by NAS (n = 9/26, 
35%), S. aureus (n = 2/26, 8%), Streptococcus dysgalac-
tiae (n = 2/26, 8%) and other species (n = 4/26, 15%). 
All S. marcescens positive milk samples had been col-
lected between September 2016 and December 2016. 
Serratia marcescens mastitis cases and SCC in bulk milk 
are shown on the timeline in Fig. 1b. Incidence of mas-
titis cases increased from 5/100 cows/year in 2015 to 
29/100 cows/year in 2016 and the proportion of cows 
slaughtered due to mastitis among all slaughtered cows 
increased from 8% in year 2015 to 13% in year 2016.
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Bacteriological results to detect potential source
Regarding Herd 1, six specimens out of 19 yielded S. 
marcescens growth: two mastitis milk samples and all 
four teat dip/teat dip container samples (fluid from 
an opened canister, fluid pumped from the canister, 
fluid from the spray bottle and the swab sample taken 
the nozzle of the spray bottle). Other milk samples, 
unopened teat dip canister, towel bucket water, drill 
water, water cup, liner or faucet samples were negative 
for S. marcescens although heavy mixed growth was 
cultured from the water cup and liner samples. All six 
S. marcescens isolates from Herd 1 were identical in the 
PFGE analysis. PFGE patterns and antimicrobial resist-
ance profiles of the isolates are represented in Fig.  2. 
Three isolates indicated AmpC activity.
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Fig. 1 a Number of Serratia marcescens intra‑mammary infections (IMI) and somatic cell count (SCC) in bulk milk of Herd 1. b Number of Serratia 
marcescens IMI and SCC in bulk milk of Herd 2
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Of Herd 2 samples, all nine specimens (two clinical 
mastitis samples, teat dip from the opened canister, and 
six teat dip specimens from different spray bottles) were 
positive for S. marcescens. All nine isolates of Herd 2 
were identical with similar antibiogram and PFGE profile 
(Fig. 2). All isolates expressed AmpC activity.
With this epidemiological “golden standard genotyp-
ing method”, the S. marcescens strains between the two 
farms showed 75% difference in the UPGMA based clus-
ter analysis (Fig.  2), thus indicating epidemiological dif-
ference of the strains, similarity cut-off being 85%.
Table  2 summarizes the 15 case reports that were 
found in the literature review. Beside the case reports 
found, additional 16 articles dealt with pathology, immu-
nology, antibiotic treatment and resistance, prevalence 
of Serratia spp. in bulk milk or mastitis milk samples. In 
many Serratia mastitis outbreaks the source of Serratia 
spp. remained unresolved (n = 7/15). The teat disinfect-
ant or equipment used in teat-dipping were shown to be 
the source for Serratia mastitis outbreak in four cases 
(n = 4/15) and suspected to be the source in one case. 
Only Lium [30] reported a fatal Serratia associated mas-
titis case, whereas subclinical and chronic mastitis were 
more commonly reported. The reviewed literature sug-
gested that culling was more common among Serratia 
infected cows than in a healthy population.
Discussion
In both herds the bacterial species in the collected sam-
ples was confirmed to be S. marcescens. Serratia marc-
escens has been reported to cause both clinical and 
subclinical mastitis outbreaks during the lactation and 
the dry period in dairy cows [31]. It is a rare cause for 
bovine mastitis in Finland [32]. During the outbreak 
situations described here, however, S. marcescens find-
ings increased drastically in both farms. Identical isolates 
from the cows, the teat dip product and spray bottles 
indicated transmission of the bacteria from a contami-
nated point source, the teat dip or spray bottles where 
the teat dip was temporarily kept, to the cow. Similar 
to a previous report [4], the negative result from the 
unopened canister and positive results from temporary 
containers demonstrated that the product itself was not 
contaminated with S. marcescens at the production unit, 
but became contaminated at the farm level. Although the 
original source for S. marcescens contamination remained 
unclear, it is likely that the source of the bacterium was 
the environment, and that daily practices promoted the 
contamination of spray bottles and pumps. Amount of 
the teat dip that was used daily was taken from a stor-
age canister via a pump that was moved to a new canister 
without cleaning. Also, spray bottles were not machine 
washed but were only flushed with tap water between 
the re-fillings. It is not known whether the bottles dried 
out properly after the washing, prior to re-filling the bot-
tle. Considering the nature of the S. marcescens and its 
ubiquitous presence in the environment, contamination 
of bottles by water splashes or by contaminated hands 
is easy in the farm environment. In addition, Serratia 
species are prone to form biofilms. The way the farms 
handled the teat dip product and its refillable contain-
ers was favourable for biofilm formation, which in part 
could have promoted the existence of S. marcescens and 
its emergence to teats of the cows. However, the presence 
of biofilms was not evaluated in our study. In this study 
water appeared not to be a source for S. marcescens. On 
the other hand, relatively few specimens from the water 
faucet areas or areas where spray bottles were handled 
Fig. 2 PFGE and antimicrobial susceptibility patterns of the Serratia marcescens isolates from the two herds. 1)Antibiogram is represented in the 
following order: sulfamethoxazole/trimethoprim, enrofloxacin, gentamicin, cefpodoksime and amikacin
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were taken and thus this source could have stayed unde-
tected. A faulty water supply has been reported to be pre-
disposing factor to Serratia mastitis [33].
Because of the ubiquitous nature of Serratia spp. in 
the environment, these bacteria are abundant on dairy 
farms. Table 2 contains information on published Serra-
tia spp. mastitis outbreaks and sources of bacteria. For 
example, their presence has been reported from bedding 
material and floors of a milking parlor [6, 7]. Serratia 
spp. has been isolated from bedding materials in areas 
where known Serratia infected lactating cows are kept, 
but not from the area of dry cows. Wilson et al. [34] and 
Hogan and Smith [35] have shown that dairy cows may 
carry Serratia spp. subclinically for several months or 
even years. Hence it is possible that leaking of milk from 
Serratia infected cows could further spread the bacteria 
to the environment. Some cases of Serratia mastitis can 
cure spontaneously but infected cows can also become 
chronic carriers. Guardo et al. [36] showed that chronic 
carriers of S. marcescens can be the source of infection 
on a milking farm. In both farms of this study, several 
infected cows had been slaughtered rapidly after infec-
tion which diminished the risk for cow to cow transmis-
sion and possibly prevented the situation from escalating 
even worse. Udder supporters were used in both farms 
of this study, which reduced the risk of environmental 
contamination.
Serratia marcescens mastitis is challenging to treat as 
the organism is intrinsically resistant to many antimi-
crobials [37, 38] due to multi-drug efflux pump(s) [39]. 
Mastitis cases caused by S. marcescens were not treated 
with antimicrobials in either of the herds of this study 
due to a lack of appropriate licensed veterinary products 
for lactating cows. Intra-mammary liquid neomycin has 
been used to cure experimentally infected S. marcescens 
quarters [40]. Positive treatment response with intra-
mammary neomycin was also documented in a cluster of 
S. liquefaciens mastitis cases in one farm [41]. Acquired 
resistance is also common in this species although S. 
marcescens isolates of this study were susceptible to 
tested agents except for cefpodoxime (Fig. 2). Neomycin 
susceptibility is not routinely tested in our laboratory, 
which is a limitation of the study. Cefpodoxime resistance 
is probably explained by the presence of chromosomal 
AmpC production which is typical for this bacterial spe-
cies. This was supported by the fact that although the 
phenotypic ESBL/AmpC testing indicated AmpC activ-
ity in majority of the strains, the zone inhibition profiles 
around the disks were not correspondent to that seen 
in isolates with plasmid-mediated AmpC production or 
hyper-production of chromosomal AmpC. However, we 
did not verify the presence of ESBL/AmpC genes by PCR.
Serratia mastitis outbreaks can be very challenging to 
control with antiseptics because Serratia spp. can carry 
both chromosomal and plasmid-encoded resistance to 
certain biocides such as chlorhexidine [42] and quater-
nary ammonium compounds [39]. Serratia spp. has been 
reported to survive in disinfectant solutions based on 
quaternary ammonium compounds (QAC), amines and 
glucoprotamin in reusable disinfection tissue dispensers 
[43], in chlorhexidine solution [44], and in amphoteric 
or alkyl amino acetate-based disinfectants [45]. Out-
breaks of Serratia mastitis in dairy herds have earlier 
been associated with chlorhexidine-containing teat dis-
infectants [4] and quaternary ammonium compounds 
[15]. S. marcescens outbreaks described in this study are 
the first ones associated with a teat dip containing a ter-
tiary alkyl amine, n,n-bis (3-aminopropyl) dodecylamine 
(CAS number 2372-82-9; known also as laurylamine 
dipropylenediamine and several other acronyms), as an 
active substance. The substance is used as a surfactant, 
disinfectant, biocide as well as preservative in cosmetic 
products [46]. In the teat disinfectant product, the con-
centration of the active substance is 0.4% correspond-
ing 4000 ppm. N,n-bis (3-aminopropyl) dodecylamine is 
reported to be active against vegetative forms of bacteria, 
but presence of proteins or organic material can reduce 
its activity [47]. Efficacy testing results were not avail-
able for the teat dip product used in these farms, but the 
active substance is currently under review for a use as a 
biocide according to EU Biocidal Products Regulation 
(EU 528/2012). We were able to find one publication in 
which the effect of the similar product containing 0.5% of 
the same active substance (CAS 2372-82-9, aminopropyl 
lauramine) was compared with iodine-based disinfect-
ant [48]. It appeared that 0.5% CAS 2372-82-9 containing 
product was far less effective in reducing bacterial colony 
counts on the teats compared to 0.2% iodine-based dis-
infectants [48]. This might indicate that the teat disin-
fectant based to CAS 2372-82-9 is not effective enough 
for this purpose. Like other Gram-negative bacteria, 
Serratia spp. may also develop higher resistance if they 
are exposed to sub-inhibitory concentrations of tenside-
based disinfectants, QAC or chlorhexidine because of 
irreversible changes in the cell wall, or if they are grow-
ing sheltered by biofilm [49]. In our study we did not have 
resources to test disinfectant resistance in S. marcescens 
strains.
Proportion of infected cows in our herds were slightly 
higher than those in published outbreaks, where approxi-
mately a tenth of herds’ cows became infected during the 
outbreak. An exception is the outbreak reported by Isaks-
son and Holmberg [13], where incidence and mortality 
were high. Culling of the cows due to Serratia mastitis 
caused high losses for the farmers of our herds. Increased 
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bulk tank milk cells have been reported by Wilson [34] 
and Bowman [14] and we found parallel change in our 
cases; bulk tank milk cells (Fig.  1b) increased clearly in 
Herd 2 at the same time as the first Serratia mastitis case 
was detected, but the change was not so obvious in Herd 
1 (Fig. 1a).
The farmers were instructed to destroy all old teat-dip 
utensils and change the post-dipping product to other 
product, which contain another active substance. The 
farmers were advised to use blanket dry cow therapy with 
product containing neomycin for a period of 1 year. No 
new Serratia mastitis cases were diagnosed during the 
following year after those changes were implemented in 
the herds.
Conclusions
Serratia marcescens was isolated repeatedly from quar-
ter milk samples from lactating cows in both farms. Our 
investigation showed that the post milking teat dip and/
or refillable containers were contaminated with S. marc-
escens and these were most likely the sources for new 
cases. The same clone of S. marcescens was isolated from 
milk samples and teat dip samples within the farms sug-
gesting the same source.
The plastic pump was moved by the farmers from one 
container to another without cleaning, and this could 
have maintained the infection. The unopened teat dis-
infectant container was not found to be contaminated, 
which suggested that the teat dip bottles or pump mecha-
nism probably became contaminated on the farms. The S. 
marcescens most likely exists in the farm environment as 
the bacterium is common.
After changing the teat-dip product and related equip-
ments herds have been free of new Serratia mastitis 
cases.
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